These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7996550)

  • 1. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
    J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a model for the delta-opioid receptor pharmacophore. 4. Residue 3 dehydrophenylalanine analogues of Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13) confirm required gauche orientation of aromatic side chain.
    Mosberg HI; Dua RK; Pogozheva ID; Lomize AL
    Biopolymers; 1996 Sep; 39(3):287-96. PubMed ID: 8756510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptors.
    Misicka A; Cavagnero S; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
    J Pept Res; 1997 Jul; 50(1):48-54. PubMed ID: 9273887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.
    Salvadori S; Bryant SD; Bianchi C; Balboni G; Scaranari V; Attila M; Lazarus LH
    J Med Chem; 1993 Nov; 36(24):3748-56. PubMed ID: 8254604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
    Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
    Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.
    Mosberg HI; Omnaas JR; Medzihradsky F; Smith CB
    Life Sci; 1988; 43(12):1013-20. PubMed ID: 2845204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
    Heyl DL; Mosberg HI
    Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.